GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Mannkind Corporation (MNKD) [hlAlert]

Rating:
Underperform
MNKD
up 51.66 %

Mannkind Corporation (MNKD) downgraded to Underperform by BofA/Merrill

Posted on: Friday,  Sep 6, 2013  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Mannkind Corporation (NASDAQ: MNKD) on 09/06/2013, when the stock price was $5.93. Since
then, Mannkind Corporation has lost 34.06% as of 01/06/2016's recent price of $3.91.
If you would have followed this BofA/Merrill's recommendation on MNKD, you would have gained 51.66% of your investment in 852 days.

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

BofA/Merrill
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/6/2013 8:25 AM Sell
None
5.93
as of 12/13/2013
1 Week up  2.73 %
1 Month up  4.04 %
3 Months up  15.44 %
1 YTD up  238.09 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/7/2013 8:25 AM Hold
None
7.44
11/5/2012 8:25 AM Buy
None
2.02

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy